دور النرويج في الريادة في علاجات الخلايا الجذعية لمتلازمة أيزنمينجر
Norway’s groundbreaking role in pioneering stem cell treatments for Eisenmenger Syndrome, a rare but life-threatening heart condition, is examined in this article. By analyzing the latest research and clinical trials, we explore the potential and challenges of this innovative approach, highlighting Norway’s contribution to advancing the field of stem cell therapy for cardiovascular diseases.





